Skip to main content

Market Overview

6 Tweets Tell The Aurinia Pharma Story

Share:
6 Tweets Tell The Aurinia Pharma Story

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are down more than 20 percent Tuesday after nearly tripling in a month’s time. For traders wondering how the stock lost its mojo, the Twitter feed of TheStreet columnist Adam Feuerstein tells the story.

Related Link: 7 Tweets That Ruined Careers

The Aurinia rumors started at around 1 p.m. Monday, when Feuerstein reported hearing that the company intended to raise $100 million.

A few minutes later, he got more specific, tweeting the deal could involve selling 15 million shares in the $6.25-$6.50 range.

At 1:44 p.m., Feuerstein continued his tweetstorm by telling his followers Aurinia “is doing a great job raising money tonight.”

When followers criticized his take on the pricing of the deal, Feuerstein fired back.

On Tuesday morning, he reported that the offering had officially been upsized to 22.3 million shares at $6.75/share.

While the stock may have lost its short-term momentum following the offering, Feuerstein believes the fundraising and the price were excellent for long-term investors. He concluded his tweetstorm with a shout out to all the people who doubted his motives on Monday afternoon.

 

Related Articles (AUPH)

View Comments and Join the Discussion!

Posted-In: Adam Feuerstein TheStreetNews Offerings Crowdsourcing Movers General Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com